Published on: November 29, 2017 at 10:30PM
Condition: Metastatic Colorectal Cancer
Interventions: Biological: CPGJ602; Biological: Cetuximab
Sponsor: Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.
Recruiting
http://ift.tt/2AiIVsJ
New cancer clinical trial: A Study of Recombinant Anti-EGFR Monoclonal Antibody in Patients With Metastatic Colorectal Cancer

Tag: cancer Clinical Trials
No comments: